Stephanie D. Turner

884 citations
9 papers · 738 indexed · h-index 7
Topics
Pharmacogenetics and Drug Metabolism (4 papers)Drug Transport and Resistance Mechanisms (3 papers)Inflammatory mediators and NSAID effects (2 papers)
Partner nations
United StatesCanada

In The Last Decade

Stephanie D. Turner

8 papers receiving 705 citations

Peers

Stephanie D. Turner
Comparison fields: 5 of 83
  • Pharmacology 439
  • Molecular Biology 214
  • Oncology 170
  • Computational Theory and Mathematics 118
  • Pharmacology 89
Replace John C. L. Erve with:
John C. L. Erve United States
Andrew P. Blanchard United States
Jouko Uusitalo Finland
Sabrina X. Zhao United States
Andre Dandeneau United States
Tian J. Yang United States
H.M. Wortelboer Netherlands
Nancy Eddy Hopkins United States
A. B. Renwick United Kingdom
L. Notley Australia
Stephanie D. Turner relative to John C. L. Erve United States John C. L. Erve's profile →
Citations per field
00.5×1.5×
John C. L. Erve · 1×
Citations per year

Countries citing papers authored by Stephanie D. Turner

Since Specialization
Citations

This map shows the geographic impact of Stephanie D. Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie D. Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie D. Turner more than expected).

Fields of papers citing papers by Stephanie D. Turner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie D. Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie D. Turner. The network helps show where Stephanie D. Turner may publish in the future.

Co-authorship network of co-authors of Stephanie D. Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie D. Turner. A scholar is included among the top collaborators of Stephanie D. Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie D. Turner. Stephanie D. Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 3
2
BIOACTIVE DENDRIMER DRUGS AS POTENTIAL THERAPEUTIC TREATMENTS FOR INFLAMMATION
0
3 115
4 139
5 35
6
The use of 3-[2-(N,N-diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a specific CYP2D6 probe in human liver microsomes.
33
7 70
8 123
9 220

About Stephanie D. Turner

Stephanie D. Turner is a scholar working on Pharmacology, Biochemistry and Orthodontics, having authored 9 papers that have together received 738 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Inflammatory mediators and NSAID effects (2 papers). The work is most often cited by research in Pharmacology (439 citations), Toxicology (47 citations) and Computational Theory and Mathematics (118 citations). Stephanie D. Turner has collaborated with scholars based in United States and Canada. Frequent co-authors include David M. Stresser, Charles L. Crespi, Vaughn P. Miller, Andrew P. Blanchard, Andre Dandeneau, John C. L. Erve, Christopher Patten, Joanne McNamara, Raman Sharma and Shangara S. Dehal. Their work appears in journals such as Analytical Biochemistry, Annals of the New York Academy of Sciences and Drug Metabolism and Disposition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026